BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. (Q48881693)

16 February 2018

title

BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. (English)

1 reference

16 February 2018

1 reference

1 reference

T V Lukowicz

1

1 reference

16 February 2018

M Fischer

2

1 reference

16 February 2018

H W Hense

3

1 reference

16 February 2018

A Döring

4

1 reference

16 February 2018

J Stritzke

5

1 reference

16 February 2018

G Riegger

6

1 reference

16 February 2018

H Schunkert

7

1 reference

16 February 2018

A Luchner

8

1 reference

16 February 2018

MONICA Investigators

9

1 reference

16 February 2018

publication date

1 June 2005

1 reference

16 February 2018

European Journal of Heart Failure

published in

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

525-531

1 reference

16 February 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Diastolic heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

The associations of body size and body composition with left ventricular mass: impacts for indexation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Plasma brain natriuretic peptide concentration: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.12.010

10.1016/J.EJHEART.2004.12.010

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018